CannTrust Adds to Leadership Team with Appointment of Greg Guyatt as CFO

CannTrust Holdings Inc. has appointed Greg Guyatt, CPA CA as Chief Financial Officer (“CFO”) effective February 19, 2019, further strengthening the Company’s leadership team. Greg comes to CannTrust from GreenSpace Brands Inc., a Canadian-based premium natural food product company, where he served as CFO. He brings more than 20 years of experience building high-performing finance teams from the consumer packaged goods, pharmaceutical and private equity sectors. Greg began his career with Deloitte.

Greg has a wealth of experience in mergers, acquisitions and other transactions including an IPO on the London Stock Exchange, and the spin-off of Sears Canada on the NASDAQ. In combination with his extensive experience with dual-listed issuers, this expertise will be instrumental to CannTrust’s financial and strategic planning leading up to listing on the NYSE.

“We are very pleased to have Greg join CannTrust and deepen the executive leadership team as we look towards our listing on the NYSE and beyond,” said Peter Aceto, Chief Executive Officer. “On behalf of everyone at CannTrust, I would like to thank Ian Abramowitz for his financial leadership over the past two years and look forward to working with him in his new role as Senior Vice President of Global Investments and Partnerships.”

In his new capacity as CannTrust’s SVP of Global Investments and Partnerships, Ian will lead CannTrust’s international strategy through the ongoing development of strategic investments and partnerships around the world.

CannTrust currently has an equity interest in Australian licensed producer Cannatrek Ltd., and STENOCARE, a Denmark-based licensed medical cannabis producer, seller and importer. Ian has been appointed to and serves as a Director on both Cannatrek and STENOCARE’s Boards. The Company is also currently evaluating prospective investments in several other countries.

“Companies around the world look to CannTrust for its expertise in cannabis for both the medical and legalized recreational markets,” said Mr. Aceto. “With Ian’s focus on international business development opportunities, we expect to further accelerate our growth with like-minded partners.”